THB335 Phase 1 SAD/MAD clinical trial on track to deliver clinical results in 1Q’25 Strong financial position with cash and cash equivalents totaling $296.1 million as of September 30, 2024 SAN ...

Investors need to pay close attention to Harmonic (HLIT) stock based on the movements in the options market lately.

Scientists in the Middle East have developed a series active filter to improve power quality in grid-tied PV systems, ...

This mode provides complementary harmonic elements that feel alive and responsive, producing melodies that feel like they’re ...

Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, ...

Third Harmonic Bio, Inc. ( (THRD) ) has released its Q3 earnings. Here is a breakdown of the information Third Harmonic Bio, Inc. presented to ...

SAN FRANCISCO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal ...

The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Third Harmonic Bio, Inc. (THRD). While the effectiveness of this highly sought-after metric is ...

The Seattle frontwoman was killed in 1993, as her punk band was on the cusp of a breakthrough. Remastered recordings provide ...

Problems plaguing power supplies to more than 5 million US households threaten to reduce efficiency and damage home ...

On May 22, 2025, Grammy-winning Americana favorites Gillian Welch, David Rawlings will perform a headlining set at ...

Third Harmonic Bio, Inc. (NASDSAQ: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory and gastrointestinal inflammatory diseases, ...